BCOR yields 3.85% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 9
Combined, BCOR + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of BCOR + JNJ for your $10,000?
BCOR targets bitcoin adopters, which the index defines as companies that have a reported ownership of at least 100 bitcoin as a corporate treasury asset. The fund includes firms of any size and industry listed in developed or emerging markets that meet the indexs minimum market-cap, liquidity, and trading requirements. Eligible securities are categorized as either: i) primary companies, which are firms that own at least 100 bitcoin in their treasury holdings, or ii) secondary companies, which include firms that, aside from owning bitcoin, generate at least 50% of their revenue from bitcoin mining. Holdings are weighted based on the function of their bitcoin holdings in corporate treasury and their free-float market capitalization. Individual security weights are capped at 20% and 2.5% for primary and secondary companies, respectively. In addition, the total weight of secondary companies is capped at 20%. The index reconstitutes and rebalances quarterly.
Full BCOR Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.